The landscape of HIV treatment has evolved significantly over the years, with a growing emphasis on developing therapies that are not only effective but also convenient for patients. Among the various treatment options available today, Biktarvy and Juluca have emerged as popular choices. Both medications are designed to manage HIV effectively, but they come with different mechanisms of action, dosing regimens, and side effect profiles. As patients and healthcare providers seek the best treatment options, understanding the nuances of these medications becomes crucial. The decision-making process involves considering factors such as efficacy, patient adherence, and potential drug interactions. In this context, patients often inquire about the differences and similarities between…